No Data
No Data
Express News | Galectin Therapeutics Appoints Khurram Jamil, M.d. to Chief Medical Officer
Galectin Therapeutics Inc.'s (NASDAQ:GALT) Largest Shareholders Are Retail Investors With 57% Ownership, Insiders Own 20%
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Galectin Therapeutics(GALT.US) Director Buys US$5,949.75 in Common Stock
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress
Express News | Galectin Therapeutics Inc: Navigate Trial Remains on Track for Interim Top-Line Readout Late in Q4 of 2024
No Data